D-0614-2026 Class II Ongoing
FDA drug recall D-0614-2026 was initiated by Amgen, Inc. on Jun 4, 2026 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 1, 2026
- Initiation Date
- Jun 4, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks ,CA 91320-1799, Made in Japan. NDC 55513-074-30
Reason for recall
CGMP Deviations
Distribution pattern
Nationwide within the United States
Code information
Lot #: 1157055, Exp. Date 1/31/2028
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0614-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026